Clinical trial Recruiting at 1 site Interventional Ages 20 to 90

Investigating neuromodulation techniques for improving gait in Parkinson's disease

Official title: Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's Disease During Different Ambulatory Complexities: An Electrophysiological and fMRI Study

Run by China Medical University Hospital · NCT06505460 · Data updated 2026-11-12

This study is testing different brain stimulation techniques to see if they can help people with Parkinson's disease improve their walking and reduce episodes of freezing while they walk.

Quick facts

Study typeInterventional
Ages20 Years to 90 Years
SexAll
Enrollment20 (estimated)
SponsorChina Medical University Hospital
Academic / other
Locations1 site (Taichung)
StatusRecruiting
StartedApril 30, 2024
Main results expectedJuly 31, 2025
Study endsJuly 31, 2027
Registry record updatedAugust 21, 2024
Trial IDNCT06505460 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 20 to 90 diagnosed with Parkinson's disease who experience freezing of gait and have not achieved satisfactory control with medication.

Probably not a fit

Patients with advanced Parkinson's disease at Hoehn and Yahr Stage 5 or those with severe comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the effects of both non-invasive and invasive neuromodulation techniques on freezing of gait (FOG) in patients with Parkinson's disease. It will utilize an artificial intelligence algorithm to identify and quantify FOG episodes through video and pressure data during walking tasks. Additionally, the study will investigate the underlying neural mechanisms of FOG using advanced electrophysiological methods and fMRI. Finally, it will assess the impact of interventions such as transcranial direct current stimulation and deep brain stimulation on gait performance in these patients.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for managing freezing of gait in Parkinson's disease patients.

How similar studies have gone: While some studies have explored neuromodulation techniques in Parkinson's disease, this specific approach combining AI and various neuromodulation methods is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients meet the diagnosis of PD based on the established consensus criteria
2. Age above 20 years old and below 90 years
3. For MRgFUS patients: a. At least one of the 3 cardinal symptoms (akinesia, tremor, rigidity) reaches an intensity of at least 2/4. b. Parkinsonian symptoms cannot be satisfactorily controlled by optimal pharmacological treatment including L-dopa and other antiparkinsonian drugs. c. stable medication for PD ≥ 30 days.
4. DBS patients must meet Taiwan Health Insurance criteria: PD duration exceeding 5 years, positive response to levodopa (≥33% UPDRS motor score improvement), and presence of motor complications (e.g., wearing off, on-off, levodopa-related dyskinesia, or medically intractable tremor).

Exclusion Criteria:

1. Congestive heart failure (Functional III or above) or advanced cancer with distant metastasis.
2. PD at Hoehn and Yahr Stage 5.
3. DBS exclusion criteria: overt dementia or major depression.

Where it's running

  • China Medical University Hospital/Neuro Depart
    Taichung, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.